Data
Bayesian vs Frequentist A/B Testing: Which Should You Use in 2026?
There are two main schools of thought for analyzing A/B tests. Frequentist tests give you a p-value and a yes/no verdict on significance. Bayesian tests give you a probability that one version is better. Both are mathematically sound. They answer slightly different questions, and the right choice depends on how your team makes decisions.
The frequentist approach
A frequentist test starts by assuming there is no difference between A and B (the null hypothesis), then asks how surprising your data would be if that were true. The answer is the p-value. If it falls below a threshold chosen in advance — usually 0.05 — you reject the null and call the result significant.
Strengths
- Well understood, widely taught and accepted by most stakeholders.
- Controls the false-positive rate at a known level, if you fix the sample size in advance and analyze once.
- Simple calculations; no assumptions about prior beliefs.
Weaknesses
- The p-value is easy to misread as “the probability B is better” — it is not.
- Checking results repeatedly and stopping when p < 0.05 inflates false positives (the peeking problem).
- Gives a binary verdict that hides useful nuance, such as “B is probably better but we are not sure.”
Run a frequentist test with the A/B test calculator.
The Bayesian approach
A Bayesian test treats each version’s true conversion rate as uncertain and describes it with a probability distribution. It starts with a prior (often a neutral one that says “any rate is equally plausible”), updates it with your data, and then compares the two distributions directly.
The output is a statement like: “There is a 95% probability that B’s conversion rate is higher than A’s.” Many tools also report the expected loss — how much you would give up, on average, if you chose B and it turned out to be worse.
Strengths
- Results are intuitive and map directly to business decisions.
- You can look at results as data arrives and make a decision when the probability (or expected loss) meets a rule you set in advance.
- Works well for low-risk, reversible changes where “probably better” is good enough.
Weaknesses
- Requires choosing a prior. With a neutral prior and decent sample sizes this has little effect, but it is one more thing to explain.
- Continuous monitoring is not a free pass — stopping on the first lucky spike still leads to more wrong decisions than a disciplined plan.
- Less familiar to some stakeholders and reviewers.
Try it with the Bayesian A/B test calculator.
Same data, two readouts
A pricing-page test produces:
- A: 5,000 visitors, 150 conversions (3.0%)
- B: 5,000 visitors, 180 conversions (3.6%)
Frequentist (two-sided): z ≈ 1.68, p ≈ 0.093. Not significant at the 5% level. Strict reading: “inconclusive.”
Bayesian (neutral prior): P(B beats A) ≈ 95%, with a 20% observed lift.
These do not contradict each other. The frequentist test asks whether the evidence is strong enough to rule out “no difference” under a strict two-sided standard. The Bayesian analysis says B is very likely better, though the size of the improvement is still uncertain. For a cheap, easily reversed change, many teams would ship B on the Bayesian reading. For a big, costly change, they might run the test longer.
Which should you use?
| Situation | Better fit |
|---|---|
| Regulated, academic or high-stakes decisions needing a fixed error rate | Frequentist with a pre-set sample size |
| Fast product and marketing iterations that are easy to roll back | Bayesian with a clear decision threshold |
| Stakeholders who want “how likely is B better?” | Bayesian |
| Teams that already have frequentist processes and dashboards | Frequentist (stay consistent) |
Rules that apply either way
- Plan the sample size. Neither method rescues a test that is far too small. Use the sample size calculator.
- Pick one primary metric in advance.
- Run full weeks to cover weekday and weekend behavior.
- Set your decision rule before you look — a p-value threshold or a probability and expected-loss threshold.
- Look at effect size, not only at significance or probability.
Key takeaways
- Frequentist: “Is the evidence strong enough to reject no difference?” Bayesian: “How likely is B better, and by how much?”
- Both are valid; they can give different-sounding answers on the same data without either being wrong.
- Discipline — planned sample sizes, one metric, pre-set rules — matters more than the method.